Skip to content

Estimating Blood [Lactate] Non-Invasively

Validation of a Non-Invasive Instrument to Estimate Blood Lactate

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05036122
Enrollment
0
Registered
2021-09-05
Start date
2026-01-01
Completion date
2026-12-01
Last updated
2026-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

High intensity exercise, Stress Testing

Brief summary

The purpose of this study is to validate the LabClasp's ability to estimate blood \[lactate\].

Interventions

DEVICELabClasp

Non-invasive device that estimates blood \[lactate\] from interstitial fluid via a proprietary algorithm. The device is placed between the first and second knuckle of a finger and gently applies slight pressure to extract interstitial fluid from the skin. Sensors within the device quickly estimate blood \[lactate\] and return a value to the subject via an accompanying tablet within 20 seconds.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

- Aim 1: * Subjects must be able to provide written consent. * Adults 18 years of age and older. * Nonsmokers. * No recent hospitalization (\< 60 days). * Ability to perform high-intensity exercise. Inclusion Criteria - Aim 2: * Subjects must be able to provide written consent to be included in the research study. * Adults 18 years of age and older. * Nonsmokers. * Current ICU patient. * Have regular blood samples taken for \[lactate\] measurements. * Have one or more risk factors for sepsis.

Exclusion criteria

- Aims 1 and 2: * History of, or active malignancy. * History of HIV with antiretroviral treatment. * Smokers. * Pregnancy.

Design outcomes

Primary

MeasureTime frameDescription
Blood [lactate] during incremental exercise1 dayMeasured via venous blood and the LabClasp
Blood [lactate] measurements in ICU patients1 dayMeasured via venous blood and the LabClasp

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORVirend Somers

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026